Disposable Endoscope Market Size, Growth | Statistics, 2028

Disposable Endoscope Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Application (Urologic Endoscopy, GI Endoscopy, Bronchoscopy, Arthroscopy, Proctoscopy, and Others) and End User (Hospitals, Diagnostic Centers, and Clinics)

Publication Month : Mar 2023

  • Report Code : TIPRE00004924
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 153
Inquire Before Buy



[Research Report] The disposable endoscope market is expected to grow from US$ 1,213.28 million in 2022 to US$ 3,096.34 million by 2028; it is estimated to record a CAGR of 16.9% during 2022–2028.

Endoscope comprises an image fiber, a light fiber, and a connected camera, which captures high-resolution images inside the body. Improper sterilization and cleaning procedures of reusable endoscope instruments may cause life-threatening infections in patients. Hence, medical and surgical professionals prefer disposable endoscopes. Disposable endoscope is a single-use endoscope that does not require sterilization or cleaning. 

The disposable endoscope market is segmented on the basis of application, end user, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The report offers insights and in-depth analysis of the market, emphasizing parameters such as market trends, technological advancements, and market dynamics, along with analyzing the competitive landscape of leading market players worldwide.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Disposable Endoscope Market: Strategic Insights

Market Size Value inUS$ 1,213.28 million in 2022
Market Size Value byUS$ 3,096.34 million by 2028
Growth rateCAGR of 16.9% from 2022 to 2028
Forecast Period2022-2028
Base Year2022
Analyst Image


Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Lucrative Regions for Disposable Endoscope Market

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
Market Insights

Rising Incidence of Hospital-Acquired Infections (HAI) due to Contaminated Endoscopes Drives Disposable Endoscope Market Growth

According to an article published in Frontiers in Endoscopy, the US reported ~20 million endoscopic procedures in July 2020, of which 600,000 are endoscopic retrograde cholangiopancreatographies (ERCPs). An increase in the presence of multi-drug resistant organisms (MDRO) on contaminated endoscopes can cause hospital-acquired infections (HAI). In recent years, endoscope-associated infections (EAIs), notably those linked to the reusable endoscopes used for ERCP (e.g., duodenoscope), have been a growing concern in the healthcare system. According to an article published in the National Library of Medicine, in December 2020, the attack rates of duodenoscope-associated outbreaks were between 6% and 20%. The same report concluded that the use of contaminated duodenoscopes during ERCP procedures can cause infections in as many as 10% of procedures. According to an article published in Cambridge University Press, in March 2022, between October 2019 and September 2020, 859 and 850 samples from reprocessed TJF-Q180V and TJF-160F/VF duodenoscopes, respectively, were collected. The overall contamination rate was 5.3%, with 91 samples from both models contaminated by high-concern organisms. According to the American Journal of Infection Control, up to 71% of reprocessed endoscopes can harbor microbial growth, leading to potentially severe complications that can ultimately compromise patient health.

According to an analysis of medical device reports by the US Food and Drug Administration (FDA) received between October 15, 2018 and March 31, 2019, 3 deaths, 45 infection cases, and 159 reports of contaminated devices were recorded due to the insufficient reprocessing of duodenoscopes used in pancreatic and bile duct procedures. Further, it states that Olympus, Fujifilm, and Pentax manufacturers have not complied with post-marketing studies for the reusable endoscopes.

Thus, there is a rising demand for disposable endoscopes across the world to avoid the cases of HAIs and risks associated with contaminated endoscopes.

Rapid Technology Advancement and Product Launches to Fuel Disposable Endoscope Market Growth in Future

The earliest generation of single-use endoscopes demonstrated their clinical value regarding cross contamination, availability, and workflow, but a performance gap compared to reusable endoscopes limited their adoption. However, in recent years, rising technological advancements in sensors, image processing software, and monitor processing power have improved image resolutions and clinical performance of single-use endoscopy products. Moreover, with single-use endoscopes, product iterations can occur at a faster pace than with reusable endoscopes. As a result, a few single-use endoscopes being launched recently have surpassed reusable endoscopes in terms of performance.

  • In July 2020, Ambu A/S launched aScope Duodeno 1.5 single-use duodenoscope for ERCP procedures. The aScope Duodeno 1.5 is designed with high-definition imagery and flexible bending angles to view the mucosa in detail and navigate the gastrointestinal tract efficiently. After the successful launch of aScope Duodeno 1.5, in February 2022, Ambu A/S announced that it has received FDA 510(k) clearance for its Ambu aScope Gastro and Ambu aBox 2, which are Ambu’s first sterile, single-use gastroscopes with updated imaging and design features. The single-use aScope Gastro solution, combined with the company's next-generation display and processing unit Ambu aBox 2, will help hospitals to perform quality and cost-effective gastroscopies at ease, across a wide range of care settings, such as endoscopy units, operating rooms (OR), intensive care units (ICU), emergency rooms (ER), and ambulatory surgery centers.
  • In April 2021, Olympus Corporation announced the expansion of its respiratory portfolio by launching the first line of single-use bronchoscopes, the H-SteriScopes. The disposable bronchoscope is available in five models with premium features that help clinicians to target, diagnose, and treat patients while enhancing workflow and productivity.
  • In May 2021, PENTAX Medical received CE mark for PENTAX Medical ONE Pulmo, a single-use bronchoscope with superior suction capacity and HD image quality. PENTAX Medical ONE Pulmo has features such as sterility with HD visualization, broadening the clinical applications beyond the standard disposable scope.

Thus, growing technological advancements and product launches of disposable endoscopes will propel the disposable endoscope market expansion during the forecast period.

Increase in Favourable Government Regulations Regarding Disposable Endoscopes to Offer Lucrative Opportunities for Disposable Endoscope Market During Forecast Period

Due to the difficulty in cleaning reusable devices for reuse and persistent contamination levels, the FDA recommends avoiding the use of duodenoscopes with fixed endcaps and replace them with disposable components, including disposable endcaps, or fully disposable duodenoscopes. The FDA urges manufacturers of disposable duodenoscope models to assist healthcare facilities with their transition plans. To reduce or eliminate infection risks for patients, FDA works with manufacturers to increase the supply of disposable caps of duodenoscopes and develop innovative designs of other devices. Currently, the FDA recommends a gradual transition to disposable duodenoscopes because it is not feasible to remove conventional, fixed endcap duodenoscopes completely. Furthermore, the FDA has ordered disposable endcaps from duodenoscope manufacturers to conduct post-market surveillance studies to gather information and verify that the new designs reduce contamination. After the completion of post-market surveillance studies by the FDA, duodenoscopes with disposable end caps are expected to be labeled with contamination rate information. The information would allow patients and healthcare professionals to make informed decisions about the potential risks associated with duodenoscope. Thus, favorable government regulation for disposable endoscopes will provide opportunities for the disposable endoscope market during the forecast period.  

End User Insights

Based on end user, the disposable endoscope market is segmented into hospitals, diagnostic centers, and clinics. The hospital segment held the largest market share in 2022, and it is expected to be the largest shareholder in the market by 2028. The endoscopy procedure uses an endoscope to examine the interior of a hollow organ or cavity inside the body. Endoscopes are inserted directly into the cavity or hollow organ. Few endoscopic examinations are particularly done in hospital settings. Cystoscopies are typically performed in a hospital outpatient setting. Ureteroscopy is performed in an operating room, and most procedures are for doctors to manage or remove kidney stones. Many ENT endoscopies for examining a patient’s nose or throat to assess breathing problems or swallowing difficulties take place in hospital inpatient and outpatient settings. Several manufacturers of disposable endoscopes manufacture and sell devices to hospitals. Ambu A/S develops, manufactures, and sells disposable endoscopes to hospitals across the world through its own company or in collaboration with third parties. Thus, the abovementioned factors drive the disposable endoscope market growth for the hospital segment.

Disposable Endoscope Market, by End User – 2022 and 2028

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
Product launches and mergers and acquisitions are a few highly adopted strategies by the players operating in the global disposable endoscope market. A few of the recent key product developments are listed below:

  • In August 2021, Boston Scientific Corporation announced the clearance of EXALT Model B Single-Use Bronchoscope designed for bedside procedures in the intensive care unit (ICU) and operating room (OR).
  • In April 2019, Prosurg Inc introduced New Neoscope Video Processing Module with light intensity control to use with commercial HD video monitors. It also introduced Neoscope Video Link Module to use with commercial laptop/tablet computers for cost effective and affordable treatment of Urological disorders in physician’ office/surgery center.

COVID-19 pandemic delayed colorectal cancer screening in Europe. According to the Italian National Screening Observatory, the accumulated delay of colorectal cancer screening experienced up to May 2020 resulted in 585,287 fewer colorectal cancer cases screening exams being conducted than in the same period of 2019. This represents a 54.9% decrease from the same period in 2019. The number of colorectal cancer screening tests decreased by 45.5% in 2020 compared with 2019, with an estimated 1,299 colorectal cancer cases going undiagnosed. An Italian multicentric study examined 41 endoscopic units in response to the 2019 outbreak. The majority of endoscopists (65.9%) were relocated to other departments, while 31 (75.6%) nurses were relocated to other hospital departments. Endoscopy units treated urgent cases only, including patients at high cancer risk.

After the relaxation of lockdown restrictions, the disposable endoscope market continued to recover from COVID-19 pandemic effects with elective procedures returning to pre-pandemic levels. There was a gradual recovery of the disposable endoscope market in Europe after the relaxation of lockdown.

Disposable Endoscope – Market Segmentation

Based on application, the disposable endoscope market is segmented into urologic endoscopy, GI endoscopy, bronchoscopy, arthroscopy, proctoscopy, and others. Based on end users, the disposable endoscope market is segmented into hospitals, diagnostics centers, and clinics. By geography, the disposable endoscope market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Company Profiles

  • Boston Scientific Corp
  • Ambu AS
  • Consis Medical Ltd
  • Hill-Rom Services Inc
  • Karl Storz SE & Coo KG
  • Flexicare (Group) Ltd
  • OBP Medical Corp
  • Parburch Medical Developments Ltd
  • Prosurg Inc
  • Coloplast Corp
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Application, and End User

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions

What is the disposable endoscope market?

Endoscope is used to perform endoscopy procedure in order to diagnose the internal body organs. It is comprised of an image fibre, a light fibre and a connected camera, which captures high resolution images inside the body. Improper sterilization and cleaning procedures of endoscope instruments may cause life threatening infections in patients. Hence, medical and surgical professionals prefer disposable endoscopes. Disposable endoscope is single use endoscope which doesn’t require sterilization or cleaning.

What are the driving factors for the disposable endoscope market across the world?

The factors driving the disposable endoscope market growth, includes rising incidence of hospital-acquired infections (HAI) due to contaminated endoscopes and increased focus on patient safety. However, accumulation of medical waste due to disposable endoscopes hinder the disposable endoscope market growth.

Who are the major players in the disposable endoscope market?

The disposable endoscope market majorly consists of the players, such as Boston Scientific Corp, Ambu AS, Consis Medical Ltd, Hill-Rom Services Inc, Karl Storz SE & Co KG, Flexicare (Group) Ltd, OBP Medical Corp, Parburch Medical Developments Ltd, Prosurg Inc, and Coloplast Corp.

What will be the CAGR of the disposable endoscope market during the forecast period?

The market is estimated to grow at a CAGR of 16.9% during the forecast period.

What was the estimated disposable endoscope market size in 2022?

The disposable endoscope market was valued at US$ 1,213.28 million in 2022.

What are the growth estimates for the disposable endoscope market till 2028?

The disposable endoscope market is expected to be valued at US$ 3,096.34 million in 2028.

Which segment is dominating the disposable endoscope market?

The disposable endoscope market, by application, is segmented into urologic endoscopy, GI endoscopy, bronchoscopy, arthroscopy, proctoscopy, and other applications. The GI endoscopy application segment held the largest share of the market in 2022. However, the urologic endoscopy segment is expected to grow at the highest CAGR during the forecast period.

The List of Companies - Disposable Endoscope Market

  1. Boston Scientific Corp
  2. Ambu AS
  3. Consis Medical Ltd
  4. Hill-Rom Services Inc
  5. Karl Storz SE & Coo KG
  6. Flexicare (Group) Ltd
  7. OBP Medical Corp
  8. Parburch Medical Developments Ltd
  9. Prosurg Inc
  10. Coloplast Corp

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports